-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Reata Pharmaceuticals Inc quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q2 2015 to Q2 2023.
- Reata Pharmaceuticals Inc Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2023 was 41.5M shares, a 13.8% increase year-over-year.
- Reata Pharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 36.5M shares, a 0.54% increase from 2021.
- Reata Pharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 36.3M shares, a 7.75% increase from 2020.
- Reata Pharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2020 was 33.7M shares, a 10.8% increase from 2019.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)